RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 145 filers reported holding RELMADA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 2.08 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $493,200 | -18.4% | 164,400 | -33.1% | 0.00% | -50.0% |
| Q2 2023 | $604,422 | -25.2% | 245,700 | -31.3% | 0.00% | 0.0% |
| Q1 2023 | $808,176 | -28.3% | 357,600 | +10.7% | 0.00% | -33.3% |
| Q4 2022 | $1,127,619 | +41.7% | 323,100 | +1402.8% | 0.00% | +50.0% |
| Q3 2022 | $796,000 | – | 21,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Guild Investment Management, Inc. | 111,550 | $274,413 | 0.39% |
| Deep Track Capital, LP | 2,837,818 | $6,981,032 | 0.32% |
| apricus wealth, LLC | 77,329 | $219,614 | 0.19% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 873,312 | $2,148,348 | 0.16% |
| Palo Alto Investors LP | 732,400 | $1,801,704 | 0.15% |
| RTW INVESTMENTS, LP | 2,131,835 | $5,244,314 | 0.10% |
| AdvisorShares Investments LLC | 112,898 | $277,729 | 0.08% |
| GSA CAPITAL PARTNERS LLP | 271,524 | $668 | 0.07% |
| Spotlight Asset Group, Inc. | 20,000 | $49,200 | 0.04% |
| Savior LLC | 3,500 | $8,610 | 0.04% |